Hope for all. The initiator of this whole program is the chairman of our energy and commerce committee, and i am very pleased to ask our distinguished chairman, chairman upton am a from michigan, for any remarks he would like to make, and then i would like to thank him for taking time. Mr. Chairman . Thank you, mr. Chairman. It is truly a bipartisan effort. We formally unveiled it this past spring, and it will be bipartisan every step of the way. Century Cures Initiative is, in fact, going to save lives. It is going to impact every family, not only in this country but perhaps around the world. It is going to keep our country the leader in innovations and accelerate the display recycle the delivery cycle. There are 7000 known diseases, but we only have treatments for about 500 of them, and that is just unacceptable. We can, and we must do better, and we will. Kindnitiatives have this of direct impact on american lives, or, as we think about our family members and Close Friends who have
Trader. Here is a record of the purchase of the stock in question right before the announcement of some new public information. What do you think they were talking about . Leakwas proof that was a from the insider. Metadata can reveal content. The point about the technology that allows analysis leads me back to the point i wanted to make in response moment ago. It is important not to lose sight of all of the other protections that are built acquisition and retention and use of the data the oldis Program Given production to the government in light of the technology. That is critical to understand. In addition to being noncontent information about the telephone queriedata can only be for counterterrorism purposes and only if there is a reasonable suspicion that the selection turn or number or aceever is associated with this fight foreign terrorist. Subsection g requires minimization procedures. It was understood that this tool data be used to obtain that could relate to a number of u. S.
This is a hearing about the pat, Patient Involvement in fda drug approvals, and i think we can agree they deserve a seat at the table. When companies are developing drugs and medical devices within the Clinical Trial process. I have long been a supporter of the department of defenses congressionallydirected medical Research Program known as the cdmrp. It funds peerreviewed research into Breast Cancer, autism, ovarian cancer, Prostate Cancer and other diseases. And since 1993 the patients have been involved and have been attar of cdmrp, and they have a consumer reviewer as part of the peerreviewed possible to represent the stakeholder community. And its been very successful in combining Patient Perspectives and needs with Scientific Research and bringing those perspectives together. Has fda, as you begin to consider improving Patient Involvement, have you looked at cdrmp to see if theres anything you can borrow from that in the drug approval process . Uhhuh. We have not, and thats a goo
Naked of shock could push economies against the zero lower bound. If it is correct that equilibrium rates in the United States and globally may be lower Going Forward than they have been historically. I think we will have to worry about these episodes more often. Of course, often there are other tools besides monetary poll 60 mime Monetary Policy has bore the brunt of responding. I think if greaters had more fiscal scope than there would be a large tool kit to respond to the zero lower bound. It seems to include nor structural bands although the situation is improving slightly. On the tendential Interest Rates. Research has been done to the one youre alluding to and points to that direction as well. Let me take you one circle further, youve beautifully demonstrated the efforts that have been undertaken from a macro prudential view. This universe being restrictive and well supervised as it is how generated the creation of parallel universes. Im just thinking of huge janet with the tool
Trials because they are being treated in places that are not running trials. We need to move this out in to the community, make those folks eligible. And im on the committee in the lung map trial, and i have really urged that we make sure that we are out there in the community so that anyone who has lung cancer has an opportunity to participate in the research and perhaps, have a more effective therapy. So, i think the Electronic Health records that its a huge different area that we are working on and how to do Clinical Trials utilizing the infrastructure that is emerging. Right, thank you very much. Chair, thanks, gentle lady, and now recognize gentleman from new jersey. Five minutes. Thank you very much, mr. Chairman. A focus of your testimony has been focused on fdas efforts on Patient Engagement. Its my understanding that clinicaltrials. Gov was intended to provide Clinical Study information for patients, Health Care Providers and researchers. But it seems to me that this site lack